CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 108 enrolled
Drug / intervention
Atorvastatindrug
Likely dose
Atorvastatin 80mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00361283
NCT00361283Phase 4Completed
CompareCT.gov

Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis

University of Florida·interventional·Posted Aug 8, 2006·Updated May 15, 2012

In Brief

A Phase 4 clinical trial evaluating Atorvastatin for Inflammation. Completed, enrolled 108 participants across 1 site.

Detailed Summary

The purpose of the study is to test whether atorvastatin (also known as Lipitor) has anti-inflammatory effects in people with no known heart disease or high cholesterol. We also are investigating whether or not genetic differences between people plays a role in the drug response.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInflammation
CountriesUnited States
CollaboratorsAmerican Heart Association, American College of Clinical Pharmacy

Timeline

Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 8, 2006
Enrollment StartJun 1, 2004
Primary CompletionDec 1, 2008
Study CompletionJan 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 19.9 years ago

Interventions

Atorvastatindrug

atorvastatin 80mg tablets given by mouth once daily for 16 weeks with follow-up visits every 4 weeks